{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:49:49Z","timestamp":1740142189412,"version":"3.37.3"},"reference-count":92,"publisher":"Bentham Science Publishers Ltd.","issue":"18","funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["88881.068062\/ 2014-01"],"award-info":[{"award-number":["88881.068062\/ 2014-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Bolsas de Produtividade em Pesquisa","doi-asserted-by":"publisher","award":["FAPERJ E_02\/2017"],"award-info":[{"award-number":["FAPERJ E_02\/2017"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPQ","doi-asserted-by":"publisher","award":["309703\/2019-0","06\/2019"],"award-info":[{"award-number":["309703\/2019-0","06\/2019"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The COVID-19 pandemic has had global catastrophic effects on financial markets,\njobs and peoples\u2019 lives. Future prevention\/therapy of COVID-19 will rely heavily\non vaccine development and attempts to repurpose drugs previously used for other microbial\ndiseases. Little attention, however, has been paid to possible difficulties and delays\nin producing these drugs. Sometimes, unfortunately, these endeavours have been politicized\nand if these two approaches founder in any way or resistance subsequently occurs,\nthen the world will be left once again to the mercy of these devastating viral pandemics.\nThis review, therefore, briefly outlines the challenges in the development of vaccines and\nrepurposed antiviral drugs, which will hopefully lead to new treatments for COVID-19.\nIt also concludes, however, that the armoury against COVID-19 urgently needs to be enlarging\ndue to the potential severity and likely future reoccurrence of new emergent viruses.\nTherefore, serious consideration is given to alternative ways of preventing and controlling\nthese pathogens that have received scant attention from the media in the present\npandemic. The development of innovative, broad-spectrum, antiviral drugs from natural\nproducts is therefore particularly advocated with the challenges involved by new regulatory\nand scientific initiatives.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867327666201027152400","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T06:19:32Z","timestamp":1603865972000},"page":"3554-3567","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19: Innovative Antiviral Drugs Required for Long-Term Prevention and Control of Coronavirus Diseases"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-3123","authenticated-orcid":true,"given":"Norman A.","family":"Ratcliffe","sequence":"first","affiliation":[{"name":"Programa de Pos-Graduacao em Ciencias e Biotecnologia, IB, Universidade Federal Fluminense, Niteroi,Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5283-1541","authenticated-orcid":true,"given":"Helena C.","family":"Castro","sequence":"additional","affiliation":[{"name":"Programa de Pos-Graduacao em Ciencias e Biotecnologia, IB, Universidade Federal Fluminense, Niteroi,Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7513-2567","authenticated-orcid":true,"given":"Izabel C.","family":"Paix\u00e3o","sequence":"additional","affiliation":[{"name":"Programa de Pos-Graduacao em Ciencias e Biotecnologia, IB, Universidade Federal Fluminense, Niteroi,Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0092-6829","authenticated-orcid":true,"given":"Cicero B.","family":"Mello","sequence":"additional","affiliation":[{"name":"Programa de Pos-Graduacao em Ciencias e Biotecnologia, IB, Universidade Federal Fluminense, Niteroi,Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature02759","volume":"430","author":"Morens D.M.","year":"2004","unstructured":"Morens D.M.; Folkers G.K.; Fauci A.S.; The challenge of emerging and re-emerging infectious diseases. Nature 2004,430(6996),242-249","journal-title":"Nature"},{"year":"2020","author":"Page M.","key":"ref=2","unstructured":"Page M.; New coronavirus: How soon will a treatment be ready and will it work? Available at:\n (accessed on: 17th Feb, 2020)2020"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"Horby P.","year":"2021","unstructured":"Horby P.; Lim W.S.; Emberson J.R.; Mafham M.; Bell J.L.; Linsell L.; Staplin N.; Brightling C.; Ustianowski A.; Elmahi E.; Prudon B.; Green C.; Felton T.; Chadwick D.; Rege K.; Fegan C.; Chappell L.C.; Faust S.N.; Jaki T.; Jeffery K.; Montgomery A.; Rowan K.; Juszczak E.; Baillie J.K.; Haynes R.; Landray M.J.; Dexamethasone in hospitalized patients with covid-19 - preliminary report. N Engl J Med RECOVERY Collaborative Group2021,384(8),693-704","journal-title":"N Engl J Med"},{"year":"2020","key":"ref=4","unstructured":"NIH clinical trial shows Remdesivir accelerates recovery from advanced COVID-19. Available at:\n (accessed on: 4th May, 2020)2020"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcvm.2020.00143","volume":"7","author":"Mascolo A.","year":"2020","unstructured":"Mascolo A.; Scavone C.; Rafaniello C.; Ferrajolo C.; Racagni G.; Berrino L.; Paolisso G.; Rossi F.; Capuano A.; Renin-angiotensin system and coronavirus disease 2019: A narrative review. Front Cardiovasc Med 2020,7,143","journal-title":"Front Cardiovasc Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.hlc.2020.05.004","volume":"29","author":"Arnold R.H.","year":"2020","unstructured":"Arnold R.H.; COVID-19 - does this disease kill due to imbalance of the renin angiotensin system (RAS) caused by genetic and gender differences in the response to viral ACE 2 attack? Heart Lung Circ 2020,29(7),964-972","journal-title":"Heart Lung Circ"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/1751-7915.13351","volume":"12","author":"Wright G.D.","year":"2019","unstructured":"Wright G.D.; Unlocking the potential of natural products in drug discovery. Microb Biotechnol 2019,12(1),55-57","journal-title":"Microb Biotechnol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1080\/17425247.2019.1676228","volume":"16","author":"Singh A.V.","year":"2019","unstructured":"Singh A.V.; Ansari M.H.D.; Laux P.; Luch A.; Micro-nanorobots: Important considerations when developing novel drug delivery platforms. Expert Opin Drug Deliv 2019,16(11),1259-1275","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e1901862","DOI":"10.1002\/adhm.201901862","volume":"9","author":"Singh A.V.","year":"2020","unstructured":"Singh A.V.; Ansari M.H.D.; Rosenkranz D.; Maharjan R.S.; Kriegel F.L.; Gandhi K.; Kanase A.; Singh R.; Laux P.; Luch A.; Artificial intelligence and machine learning in computational nanotoxicology: Unlocking and empowering nanomedicine. Adv Healthc Mater 2020,9(17),e1901862","journal-title":"Adv Healthc Mater"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.20506\/rst.23.2.1513","volume":"23","author":"Saif L.J.","year":"2004","unstructured":"Saif L.J.; Animal coronaviruses: What can they teach us about the severe acute respiratory syndrome? Rev Sci Tech 2004,23(2),643-660","journal-title":"Rev Sci Tech"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jmv.25762","volume":"92","author":"Wang C.","year":"2020","unstructured":"Wang C.; Liu Z.; Chen Z.; Huang X.; Xu M.; He T.; Zhang Z.; The establishment of reference sequence for SARS-CoV-2 and variation analysis. J Med Virol 2020,92(6),667-674","journal-title":"J Med Virol"},{"key":"ref=12","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.09.20148429","author":"Seow J.","year":"2020","unstructured":"Seow J.; Graham C.; Merrick B.; Acors S.; Steel K. J. A.; Hemmings O.; O\u2019Bryne A.; Kouphou N.; Pickering S.; Galao R.; Betancor G.; Wilson H. D.; Signell A. W.; Winstone H.; Kerridge C.; Temperton N.; Snell L.; Bisnauthsing K.; Moore A.; Green A.; Martinez L.; Stokes B.; Honey J.; Izquierdo-Barras A.; Arbane G.; Patel A.; Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection medRxiv 2020"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.31219\/osf.io\/gubys","author":"Bhadra B.","year":"2020","unstructured":"Bhadra B.; Jalali S.; Dasgupta S.; Mutation analysis of structural and non-structural proteins indicated that the death rate of covid-19 pandemic may significantly reduce by the end of 2020. OSF Preprints 2020","journal-title":"OSF Preprints"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.13.990226","author":"Bao L.","year":"2020","unstructured":"Bao L.; Deng W.; Gao H.; Xiao C.; Liu J.; Xue J.; Lv Q.; Liu J.; Yu P.; Xu Y.; Qi F.; Qu Y.; Li F.; Xiang Z.; Yu H.; Gong S.; Liu M.; Wang G.; Wang S.; Song Z.; Liu Y.; Zhao W.; Han Y.; Zhao L.; Liu X.; Wei Q.; Qin C.; Lack of reinfection in rhesus macaques infected with SARS-CoV-2. bioRxiv 2020","journal-title":"bioRxiv"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e02107","DOI":"10.1128\/JCM.02107-20","volume":"58","author":"Addetia A.","year":"2020","unstructured":"Addetia A.; Crawford K.H.D.; Dingens A.; Zhu H.; Roychoudhury P.; Huang M.L.; Jerome K.R.; Bloom J.D.; Greninger A.L.; Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate. J Clin Microbiol 2020,58(11),e02107-e02120","journal-title":"J Clin Microbiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"20160294","DOI":"10.1098\/rstb.2016.0294","volume":"372","author":"Rojek A.M.","year":"2017","unstructured":"Rojek A.M.; Horby P.W.; Offering patients more: How the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections. Philos Trans R Soc Lond B Biol Sci 2017,372(1721),20160294","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"year":"2020","key":"ref=17","unstructured":"First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response. Available at:\n (accessed on: 20th Jan, 2020)2020"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"20140150","DOI":"10.1098\/rstb.2014.0150","volume":"370","author":"Barocchi M.A.","year":"2015","unstructured":"Barocchi M.A.; Rappuoli R.; Delivering vaccines to the people who need them most. Philos Trans R Soc Lond B Biol Sci 2015,370(1671),20140150","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1056\/NEJMms1215400","volume":"369","author":"van Panhuis W.G.","year":"2013","unstructured":"van Panhuis W.G.; Grefenstette J.; Jung S.Y.; Chok N.S.; Cross A.; Eng H.; Lee B.Y.; Zadorozhny V.; Brown S.; Cummings D.; Burke D.S.; Contagious diseases in the United States from 1888 to the present. N Engl J Med 2013,369(22),2152-2158","journal-title":"N Engl J Med"},{"year":"2019","key":"ref=20","unstructured":"Gates Notes, the blog of Bill Gates. The next epidemic is coming. Here\u2019s how we can make sure we\u2019re ready. Available at:\n (accessed on: 23rd Dec, 2019)2019"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00103-019-03061-2","volume":"63","author":"Bernasconi V.","year":"2020","unstructured":"Bernasconi V.; Kristiansen P.A.; Whelan M.; Rom&#xE1;n R.G.; Bettis A.; Yimer S.A.; Gurry C.; Andersen S.R.; Yeskey D.; Mandi H.; Kumar A.; Holst J.; Clark C.; Cramer J.P.; R&#xF8;ttingen J-A.; Hatchett R.; Saville M.; Norheim G.; Developing vaccines against epidemic-prone emerging infectious diseases. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020,63(1),65-73","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"year":"2020","key":"ref=22","unstructured":"Scientists race to develop a coronavirus vaccine. Available at:\n (accessed on: Feb 3rd, 2020)2020"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"Wu A.","year":"2020","unstructured":"Wu A.; Peng Y.; Huang B.; Ding X.; Wang X.; Niu P.; Meng J.; Zhu Z.; Zhang Z.; Wang J.; Sheng J.; Quan L.; Xia Z.; Tan W.; Cheng G.; Jiang T.; Genome Composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 2020,27(3),325-328","journal-title":"Cell Host Microbe"},{"year":"2020","key":"ref=24","unstructured":"FDA orders market pullout of Dengvaxia vaccine. Available at:\n (accessed on: 30th Jan, 2020)2020"},{"year":"2020","key":"ref=25","unstructured":"First FDA-approved vaccine for the prevention of dengue disease in endemic regions. Available at:\n (accessed on: 9th Dec, 2020)2020"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"m3205","DOI":"10.1136\/bmj.m3205","volume":"370","author":"Mahase E.","year":"2020","unstructured":"Mahase E.; Covid-19: Russia approves vaccine without large scale testing or published results. BMJ 2020,370,m3205","journal-title":"BMJ"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/21645515.2015.1093263","volume":"12","author":"Wiedermann U.","year":"2016","unstructured":"Wiedermann U.; Garner-Spitzer E.; Wagner A.; Primary vaccine failure to routine vaccines: Why and what to do? Hum Vaccin Immunother 2016,12(1),239-243","journal-title":"Hum Vaccin Immunother"},{"year":"2019","key":"ref=28","unstructured":"United Nations Digital Library. Al-Thani, Ahmed Bin Saif. A\/34\/251 9 General debate. UN. General assembly (34th sess.: 1979-1980)--general debate. Available at:\n (accessed on: 11th Jan, 2019)2019"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/geb.13045","volume":"29","author":"Wells K.","year":"2020","unstructured":"Wells K.; Morand S.; Wardeh M.; Baylis M.; Distinct spread of DNA and RNA viruses among mammals amid prominent role of domestic species. Glob Ecol Biogeogr 2020,29(3),470-481","journal-title":"Glob Ecol Biogeogr"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41577-020-0402-6","volume":"20","author":"Chen Z.","year":"2020","unstructured":"Chen Z.; John Wherry E.; T cell responses in patients with COVID-19. Nat Rev Immunol 2020,20(9),529-536","journal-title":"Nat Rev Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.1128\/JVI.01473-15","volume":"89","author":"Calland N.","year":"2015","unstructured":"Calland N.; Sahuc M-E.; Belouzard S.; P&#xE8;ne V.; Bonnafous P.; Mesalam A.A.; Deloison G.; Descamps V.; Sahpaz S.; Wychowski C.; Lambert O.; Brodin P.; Duverlie G.; Meuleman P.; Rosenberg A.R.; Dubuisson J.; Rouill&#xE9; Y.; S&#xE9;ron K.; Polyphenols inhibit hepatitis C virus entry by a new mechanism of action. J Virol 2015,89(19),10053-10063","journal-title":"J Virol"},{"year":"2020","key":"ref=32","unstructured":"WHO. Global health observatory. HIV\/AIDS. Available at:\n (accessed on: 3rd March, 2020)2020"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jinf.2016.04.016","volume":"72","author":"Fitzgerald F.","year":"2016","unstructured":"Fitzgerald F.; Awonuga W.; Shah T.; Youkee D.; Ebola response in Sierra Leone: The impact on children. J Infect 2016,72(Suppl.),S6-S12","journal-title":"J Infect"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1016\/S2214-109X(20)30114-5","volume":"8","author":"Mitj&#xE0; O.","year":"2020","unstructured":"Mitj&#xE0; O.; Clotet B.; Use of antiviral drugs to reduce COVID-19 transmission. Lancet Glob Health 2020,8(5),e639-e640","journal-title":"Lancet Glob Health"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P.","year":"2020","unstructured":"Mehta P.; McAuley D.F.; Brown M.; Sanchez E.; Tattersall R.S.; Manson J.J.; COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet HLH Across Speciality Collaboration, UK2020,395(10229),1033-1034","journal-title":"Lancet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1590\/1516-3180.2020.0208.r1.15062020","volume":"138","author":"Rabby M.I.I.","year":"2020","unstructured":"Rabby M.I.I.; Hossain F.; Study of ongoing registered clinical trials on COVID-19: A narrative review. Sao Paulo Med J 2020,138(5),441-456","journal-title":"Sao Paulo Med J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","volume":"586","author":"Riva L.","year":"2020","unstructured":"Riva L.; Yuan S.; Yin X.; Martin-Sancho L.; Matsunaga N.; Pache L.; Burgstaller-Muehlbacher S.; De Jesus P.D.; Teriete P.; Hull M.V.; Chang M.W.; Chan J.F-W.; Cao J.; Poon V.K-M.; Herbert K.M.; Cheng K.; Nguyen T.H.; Rubanov A.; Pu Y.; Nguyen C.; Choi A.; Rathnasinghe R.; Schotsaert M.; Miorin L.; Dejosez M.; Zwaka T.P.; Sit K-Y.; Martinez-Sobrido L.; Liu W-C.; White K.M.; Chapman M.E.; Lendy E.K.; Glynne R.J.; Albrecht R.; Ruppin E.; Mesecar A.D.; Johnson J.R.; Benner C.; Sun R.; Schultz P.G.; Su A.I.; Garc&#xED;a-Sastre A.; Chatterjee A.K.; Yuen K-Y.; Chanda S.K.; Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature 2020,586(7827),113-119","journal-title":"Nature"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3389\/fimmu.2020.01439","volume":"11","author":"Colafrancesco S.","year":"2020","unstructured":"Colafrancesco S.; Scrivo R.; Barbati C.; Conti F.; Priori R.; Targeting the immune system for pulmonary inflammation and cardiovascular complications in COVID-19 patients. Front Immunol 2020,11,1439","journal-title":"Front Immunol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"Li G.","year":"2020","unstructured":"Li G.; De Clercq E.; Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020,19(3),149-150","journal-title":"Nat Rev Drug Discov"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"Wu C.","year":"2020","unstructured":"Wu C.; Liu Y.; Yang Y.; Zhang P.; Zhong W.; Wang Y.; Wang Q.; Xu Y.; Li M.; Li X.; Zheng M.; Chen L.; Li H.; Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 2020,10(5),766-788","journal-title":"Acta Pharm Sin B"},{"year":"2020","author":"Duddu P.","key":"ref=41","unstructured":"Duddu P.; Coronavirus outbreak: Top coronavirus drugs and vaccines in development. Available at:\n (assecced on: 16th April, 2020)2020"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"Beigel J.H.","year":"2020","unstructured":"Beigel J.H.; Tomashek K.M.; Dodd L.E.; Mehta A.K.; Zingman B.S.; Kalil A.C.; Hohmann E.; Chu H.Y.; Luetkemeyer A.; Kline S.; Lopez de Castilla D.; Finberg R.W.; Dierberg K.; Tapson V.; Hsieh L.; Patterson T.F.; Paredes R.; Sweeney D.A.; Short W.R.; Touloumi G.; Lye D.C.; Ohmagari N.; Oh M.D.; Ruiz-Palacios G.M.; Benfield T.; F&#xE4;tkenheuer G.; Kortepeter M.G.; Atmar R.L.; Creech C.B.; Lundgren J.; Babiker A.G.; Pett S.; Neaton J.D.; Burgess T.H.; Bonnett T.; Green M.; Makowski M.; Osinusi A.; Nayak S.; Lane H.C.; ACTT-1 Study Group Members. Remdesivir for the treatment of covid-19 - preliminary report. N Engl J Med 2020,383(19),1813-1826","journal-title":"N Engl J Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","volume":"3","author":"Borba M.G.S.","year":"2020","unstructured":"Borba M.G.S.; Val F.F.A.; Sampaio V.S.; Alexandre M.A.A.; Melo G.C.; Brito M.; Mour&#xE3;o M.P.G.; Brito-Sousa J.D.; Ba&#xED;a-da-Silva D.; Guerra M.V.F.; Hajjar L.A.; Pinto R.C.; Balieiro A.A.S.; Pacheco A.G.F.; Santos J.D.O.; Naveca F.G.; Xavier M.S.; Siqueira A.M.; Schwarzbold A.; Croda J.; Nogueira M.L.; Romero G.A.S.; Bassat Q.; Fontes C.J.; Albuquerque B.C.; Daniel-Ribeiro C-T.; Monteiro W.M.; Lacerda M.V.G.; \nEffect of high \nvs\nlow doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Infection. JAMA Netw Open CloroCovid-19 Team2020,3(4),e208857","journal-title":"JAMA Netw Open"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"Monteil V.","year":"2020","unstructured":"Monteil V.; Kwon H.; Prado P.; Hagelkr&#xFC;ys A.; Wimmer R.A.; Stahl M.; Leopoldi A.; Garreta E.; Hurtado Del Pozo C.; Prosper F.; Romero J.P.; Wirnsberger G.; Zhang H.; Slutsky A.S.; Conder R.; Montserrat N.; Mirazimi A.; Penninger J.M.; Inhibition of SARS-CoV-2 Infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 2020,181(4),905-913.e7","journal-title":"Cell"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"065","DOI":"10.29328\/journal.ijcv.1001017","volume":"4","author":"Waris A.","year":"2020","unstructured":"Waris A.; Ali M.; Khan A.U.; Ali A.; Baset A.; Role of nanotechnology in diagnosing and treating covid-19 during the pandemic. Int J Clin Virol 2020,4(1),065-070","journal-title":"Int J Clin Virol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"104882","DOI":"10.1016\/j.phrs.2020.104882","volume":"157","author":"Zhang D.","year":"2020","unstructured":"Zhang D.; Zhang B.; Lv J-T.; Sa R-N.; Zhang X-M.; Lin Z-J.; The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacol Res 2020,157,104882","journal-title":"Pharmacol Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12967-020-02442-5","volume":"18","author":"Zhu R.F.","year":"2020","unstructured":"Zhu R.F.; Gao Y.L.; Robert S-H.; Gao J.P.; Yang S.G.; Zhu C.T.; Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19). J Transl Med 2020,18(1),274","journal-title":"J Transl Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"100481","DOI":"10.1016\/j.imr.2020.100481","volume":"9","author":"Pang B.","year":"2020","unstructured":"Pang B.; Zhang J.; Lee M.S.; Zheng W.; Enlightenment from clinical trials on Chinese medicine for coronavirus disease 2019 (COVID-19). Integr Med Res 2020,9(3),100481","journal-title":"Integr Med Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.eng.2018.11.011","volume":"5","author":"Wang J.","year":"2019","unstructured":"Wang J.; Xu C.; Wong Y.K.; Li Y.; Liao F.; Jiang T.; Tu Y.; Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering 2019,5(1),32-39","journal-title":"Engineering"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"Tahir Ul Qamar M.","year":"2020","unstructured":"Tahir Ul Qamar M.; Alqahtani S.M.; Alamri M.A.; Chen L.L.; Structural basis of SARS-CoV-2 3CL and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal 2020,10(4),313-319","journal-title":"J Pharm Anal"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/17460441.2019.1582639","volume":"14","author":"Li F.","year":"2019","unstructured":"Li F.; Wang Y.; Li D.; Chen Y.; Dou Q.P.; Are we seeing a resurgence in the use of natural products for new drug discovery? Expert Opin Drug Discov 2019,14(5),417-420","journal-title":"Expert Opin Drug Discov"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/485439a","volume":"485","author":"Lewis K.","year":"2012","unstructured":"Lewis K.; Antibiotics: Recover the lost art of drug discovery. Nature 2012,485(7399),439-440","journal-title":"Nature"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/md18040199","volume":"18","author":"Albarano L.","year":"2020","unstructured":"Albarano L.; Esposito R.; Ruocco N.; Costantini M.; Genome mining as new challenge in natural products discovery. Mar Drugs 2020,18(4),199","journal-title":"Mar Drugs"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5483\/BMBRep.2017.50.3.221","volume":"50","author":"Ahn K.","year":"2017","unstructured":"Ahn K.; The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep 2017,50(3),111-116","journal-title":"BMB Rep"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/10715762.2019.1636045","volume":"53","author":"Costa J.G.","year":"2019","unstructured":"Costa J.G.; Vidovic B.; Saraiva N.; do C&#xE9;u Costa M.; Del Favero G.; Marko D.; Oliveira N.G.; Fernandes A.S.; Contaminants: A dark side of food supplements? Free Radic Res 2019,53(sup1),1113-1135","journal-title":"Free Radic Res"},{"year":"2020","key":"ref=56","unstructured":"WHO. Regional Office for the Western Pacific. Research guidelines for evaluating the safety and efficacy of herbal medicines. Manila: WHO Regional Office for the Western Pacific. Available at:\n (accessed at: 3rd Feb, 2020)2020"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4103\/0975-7406.168035","volume":"7","author":"Parveen A.","year":"2015","unstructured":"Parveen A.; Parveen B.; Parveen R.; Ahmad S.; Challenges and guidelines for clinical trial of herbal drugs. J Pharm Bioallied Sci 2015,7(4),329-333","journal-title":"J Pharm Bioallied Sci"},{"journal-title":"WHO Global Report on Traditional and Complementary Medicine","year":"2020","key":"ref=58","unstructured":"World Health Organization. WHO Global Report on Traditional and Complementary Medicine Available at:\n (accessed on: 3rd Feb, 2020)2020"},{"year":"2020","key":"ref=59","unstructured":"Complementary, alternative, or integrative health: what\u2019s in a name? Available at:\n (accessed on: 3rd Feb, 2020)2020"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","volume":"160","author":"Naik B.","year":"2020","unstructured":"Naik B.; Gupta N.; Ojha R.; Singh S.; Prajapati V.K.; Prusty D.; High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. Int J Biol Macromol 2020,160,1-17","journal-title":"Int J Biol Macromol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13659-020-00253-1","volume":"10","author":"Narkhede R.R.","year":"2020","unstructured":"Narkhede R.R.; Pise A.V.; Cheke R.S.; Shinde S.D.; \nRecognition of natural products as potential inhibitors of COVID-19 main protease (mpro): \nin-silico\nevidences. Nat Prod Bioprospect 2020,10(5),297-306","journal-title":"Nat Prod Bioprospect"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e0130788","DOI":"10.1371\/journal.pone.0130788","volume":"10","author":"Chernysh S.","year":"2015","unstructured":"Chernysh S.; Gordya N.; Suborova T.; Insect antimicrobial peptide complexes prevent resistance development in bacteria. PLoS One 2015,10(7),e0130788","journal-title":"PLoS One"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"112230","DOI":"10.1016\/j.jep.2019.112230","volume":"246","author":"Heinrich M.","year":"2020","unstructured":"Heinrich M.; Appendino G.; Efferth T.; F&#xFC;rst R.; Izzo A.A.; Kayser O.; Pezzuto J.M.; Viljoen A.; Best practice in research - Overcoming common challenges in phytopharmacological research. J Ethnopharmacol 2020,246,112230","journal-title":"J Ethnopharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ptr.6700","volume":"34","author":"Islam M.T.","year":"2020","unstructured":"Islam M.T.; Sarkar C.; El-Kersh D.M.; Jamaddar S.; Uddin S.J.; Shilpi J.A.; Mubarak M.S.; Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytother Res 2020,34(10),2471-2492","journal-title":"Phytother Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1043471","DOI":"10.1155\/2020\/1043471","volume":"2020","author":"Joshi B.","year":"2020","unstructured":"Joshi B.; Panda S.K.; Jouneghani R.S.; Liu M.; Parajuli N.; Leyssen P.; Neyts J.; Luyten W.; Antibacterial, antifungal, antiviral, and anthelmintic activities of medicinal plants of Nepal selected based on ethnobotanical evidence. Evid Based Complement Alternat Med 2020,2020,1043471","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"253643","DOI":"10.1093\/ecam\/nep187","volume":"2011","author":"Astani A.","year":"2011","unstructured":"Astani A.; Reichling J.; Schnitzler P.; Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med 2011,2011,253643","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"23379","DOI":"10.1039\/D0RA03774E","volume":"10","author":"Antonio A. da S.","year":"2020","unstructured":"Antonio A. da S.; Wiedemann L.S.M.; Veiga-Junior V.F.; Natural products\u2019 role against covid-19. RSC Advances 2020,10(39),23379-23393","journal-title":"RSC Advances"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202003.0226.v1","author":"Khaerunnisa S.","year":"2020","unstructured":"Khaerunnisa S.; Kurniawan H.; Awaluddin R.; Suhartati S.; Soetjipto S.; Potential inhibitor of covid-19 main protease (M) from several medicinal plant compounds by molecular docking study. Preprints 2020","journal-title":"Preprints"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"104146","DOI":"10.1016\/j.jff.2020.104146","volume":"73","author":"Chojnacka K.","year":"2020","unstructured":"Chojnacka K.; Witek-Krowiak A.; Skrzypczak D.; Mikula K.; M\u0142ynarz P.; Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus. J Funct Foods 2020,73,104146","journal-title":"J Funct Foods"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Jin Z.","year":"2020","unstructured":"Jin Z.; Du X.; Xu Y.; Deng Y.; Liu M.; Zhao Y.; Zhang B.; Li X.; Zhang L.; Peng C.; Duan Y.; Yu J.; Wang L.; Yang K.; Liu F.; Jiang R.; Yang X.; You T.; Liu X.; Yang X.; Bai F.; Liu H.; Liu X.; Guddat L.W.; Xu W.; Xiao G.; Qin C.; Shi Z.; Jiang H.; Rao Z.; Yang H.; Structure of M from SARS-CoV-2 and discovery of its inhibitors. Nature 2020,582(7811),289-293","journal-title":"Nature"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"Dai W.","year":"2020","unstructured":"Dai W.; Zhang B.; Jiang X-M.; Su H.; Li J.; Zhao Y.; Xie X.; Jin Z.; Peng J.; Liu F.; Li C.; Li Y.; Bai F.; Wang H.; Cheng X.; Cen X.; Hu S.; Yang X.; Wang J.; Liu X.; Xiao G.; Jiang H.; Rao Z.; Zhang L-K.; Xu Y.; Yang H.; Liu H.; Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 2020,368(6497),1331-1335","journal-title":"Science"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s13346-019-00691-6","volume":"10","author":"Ben-Shabat S.","year":"2020","unstructured":"Ben-Shabat S.; Yarmolinsky L.; Porat D.; Dahan A.; Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies. Drug Deliv Transl Res 2020,10(2),354-367","journal-title":"Drug Deliv Transl Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3389\/fimmu.2020.01451","volume":"11","author":"Colunga Biancatelli R.M.L.","year":"2020","unstructured":"Colunga Biancatelli R.M.L.; Berrill M.; Catravas J.D.; Marik P.E.; Quercetin and vitamin c: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Front Immunol 2020,11,1451","journal-title":"Front Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"114123","DOI":"10.1016\/j.bcp.2020.114123","volume":"178","author":"Williamson G.","year":"2020","unstructured":"Williamson G.; Kerimi A.; Testing of natural products in clinical trials targeting the SARS-CoV-2 (Covid-19) viral spike protein-angiotensin converting enzyme-2 (ACE2) interaction. Biochem Pharmacol 2020,178,114123","journal-title":"Biochem Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1177\/1934578X1801300914","volume":"13","author":"Bilia A.R.","year":"2018","unstructured":"Bilia A.R.; Piazzini V.; Asprea M.; Risaliti L.; Vanti G.; Bergonzi M.C.; Plants extracts loaded in nanocarriers: an emergent formulating approach. Nat Prod Commun 2018,13(9)","journal-title":"Nat Prod Commun"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"3702518","DOI":"10.1155\/2019\/3702518","volume":"2019","author":"Lombardo D.","year":"2019","unstructured":"Lombardo D.; Kiselev M.A.; Caccamo M.T.; Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater 2019,2019,3702518","journal-title":"J Nanomater"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","volume":"14","author":"Chauhan G.","year":"2020","unstructured":"Chauhan G.; Madou M.J.; Kalra S.; Chopra V.; Ghosh D.; Martinez-Chapa S.O.; Nanotechnology for covid-19: therapeutics and vaccine research. ACS Nano 2020,14(7),7760-7782","journal-title":"ACS Nano"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-020-0757-7","volume":"15","year":"2020","unstructured":"Nanotechnology versus coronavirus. Nat Nanotechnol 2020,15(8),617-617","journal-title":"Nat Nanotechnol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1021\/acsnano.0c03697","volume":"14","author":"Weiss C.","year":"2020","unstructured":"Weiss C.; Carriere M.; Fusco L.; Capua I.; Regla-Nava J.A.; Pasquali M.; Scott J.A.; Vitale F.; Unal M.A.; Mattevi C.; Bedognetti D.; Merko&#xE7;i A.; Tasciotti E.; Yilmazer A.; Gogotsi Y.; Stellacci F.; Delogu L.G.; Toward nanotechnology-enabled approaches against the covid-19 pandemic. ACS Nano 2020,14(6),6383-6406","journal-title":"ACS Nano"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ecam\/neh032","volume":"1","author":"Cooper E.L.","year":"2004","unstructured":"Cooper E.L.; Drug discovery, cam and natural products. Evid Based Complement Alternat Med 2004,1(3),215-217","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-319-69075-9_3","author":"Ancheeva E.","year":"2018","unstructured":"Ancheeva E.; El-Neketi M.; Daletos G.; Ebrahim W.; Song W.; Lin W.; Proksch P.;  Grand Challenges in Marine Biotechnology 2018,97-155","journal-title":"Grand Challenges in Marine Biotechnology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/md18010008","volume":"18","author":"Rosa G.P.","year":"2019","unstructured":"Rosa G.P.; Tavares W.R.; Sousa P.M.C.; Pag&#xE8;s A.K.; Seca A.M.L.; Pinto D.C.G.A.; \nSeaweed secondary metabolites with beneficial health effects: an overview of successes in in vivo\nstudies and clinical trials. Mar Drugs 2019,18(1),8","journal-title":"Mar Drugs"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.3389\/fmicb.2019.02426","volume":"10","author":"Cirne-Santos C.C.","year":"2019","unstructured":"Cirne-Santos C.C.; Barros C.S.; Nogueira C.C.R.; Azevedo R.C.; Yamamoto K.A.; Meira G.L.S.; de Vasconcelos Z.F.M.; Ratcliffe N.A.; Teixeira V.L.; Schmidt-Chanasit J.; Ferreira D.F.; Paix&#xE3;o I.C.N.P.; Inhibition by marine algae of chikungunya virus isolated from patients in a recent disease outbreak in Rio de Janeiro. Front Microbiol 2019,10,2426","journal-title":"Front Microbiol"},{"key":"ref=84","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-92486-1_20","author":"Grice I.D.","year":"2018","unstructured":"Grice I.D.; Mariottini G.L.;  Results Probl Cell Differ 65, 439-475.2018","journal-title":"Results Probl Cell Differ"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1016\/j.bmc.2013.04.026","volume":"21","author":"Park J-Y.","year":"2013","unstructured":"Park J-Y.; Kim J.H.; Kwon J.M.; Kwon H-J.; Jeong H.J.; Kim Y.M.; Kim D.; Lee W.S.; Ryu Y.B.; \nDieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae \nEcklonia cava. Bioorg Med Chem 2013,21(13),3730-3737","journal-title":"Bioorg Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/md18040225","volume":"18","author":"Gentile D.","year":"2020","unstructured":"Gentile D.; Patamia V.; Scala A.; Sciortino M.T.; Piperno A.; Rescifina A.; Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study. Mar Drugs 2020,18(4),225","journal-title":"Mar Drugs"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/mi11040448","volume":"11","author":"Singh A.V.","year":"2020","unstructured":"Singh A.V.; Ansari M.H.D.; Mahajan M.; Srivastava S.; Kashyap S.; Dwivedi P.; Pandit V.; Katha U.; Sperm cell driven microrobots-emerging opportunities and challenges for biologically inspired robotic design. Micromachines (Basel) 2020,11(4),448","journal-title":"Micromachines (Basel)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1021\/acs.langmuir.9b03665","volume":"36","author":"Singh A.V.","year":"2020","unstructured":"Singh A.V.; Kishore V.; Santomauro G.; Yasa O.; Bill J.; Sitti M.; Mechanical coupling of puller and pusher active microswimmers influences motility. Langmuir 2020,36(19),5435-5443","journal-title":"Langmuir"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.15761\/FNN.1000S2005","volume":"5","author":"Vikram Singh A.","year":"2019","unstructured":"Vikram Singh A.; Laux P.; Luch A.; Balkrishnan S.; Prasad Dakua S.; Bottom-UP assembly of nanorobots: Extending synthetic biology to complex material design. Front Nanosci Nanotech 2019,5","journal-title":"Front Nanosci Nanotech"},{"year":"2020","key":"ref=90","unstructured":"COVID-19 vaccine tracker. Available at:\n (accessed on: 18th Jan, 2020)2020"},{"key":"ref=91","doi-asserted-by":"publisher","DOI":"10.34297\/AJBSR.2020.09.001356","volume":"9","author":"Santarpia G.","year":"2020","unstructured":"Santarpia G.; Potential role of ACE2 inhibition in COVID-19 severity. AJBSR 2020,9(1)","journal-title":"AJBSR"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.abc0870","volume":"369","author":"Chan K.K.","year":"2020","unstructured":"Chan K.K.; Dorosky D.; Sharma P.; Abbasi S.A.; Dye J.M.; Kranz D.M.; Herbert A.S.; Procko E.; Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science 2020,369(6508),1261-1265","journal-title":"Science"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666201027152400","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187255\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666201027152400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T15:13:15Z","timestamp":1654441995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187255\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":92,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666201027152400","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-05-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}